Bromosaffrole 5-(2-bromopropyl)-1-3-benzodioxole CAS: 5463-71-8

CAS NO: 5463-71-8
Bromosaffrole 5-(2-bromopropyl)-1-3-benzodioxole
Chemical Name: Bromosaffrole
Molecular Formula: C10H11BrO2
Formula Weight: 243.1
CAS No.: 5463-71-8
Description Review
Description

Bromosaffrole, also known as 5-(2-bromopropyl)-1-3-benzodioxole, is an organic compound with the molecular formula C11H11BrO2 and a formula weight of 255.11 g/mol. It has a CAS number of 5463-71-8 and is commonly used in the synthesis of a variety of compounds, including pharmaceuticals, fragrances, and pesticides. In this article, we will explore the top ten keywords related to Bromosaffrole, along with its synonyms, health benefits, potential effects, product mechanism, safety, side effects, and dosing information.

Top Ten Keywords:

  1. Bromosaffrole
  2. Benzodioxole
  3. Organic compound
  4. Chemical synthesis
  5. Enzyme inhibitor
  6. Intermediates
  7. Pharmaceuticals
  8. Fragrances
  9. Pesticides
  10. Molecular weight

Synonyms:

  • 2-bromo-1-(3,4-methylenedioxyphenyl)propan-1-one
  • 1-(3,4-methylenedioxyphenyl)-2-bromo-1-propanone
  • 5-(2-bromopropyl)benzo[d][1,3]dioxole
  • 1,3-benzodioxole-5-propanone-2-bromopropyl

Health Benefits:

Bromosaffrole has no direct health benefits for humans, as it is primarily used in the synthesis of other compounds. However, it can be used to synthesize pharmaceuticals that have therapeutic benefits for humans.

Potential Effects:

The potential effects of Bromosaffrole are related to its use as a chemical intermediate. It is commonly used in the manufacture of pharmaceuticals, fragrances, and pesticides. Additionally, Bromosaffrole can act as an enzyme inhibitor, affecting various metabolic pathways in the body.

Product Mechanism:

Bromosaffrole is typically synthesized using chemical methods. It is used as an intermediate in the synthesis of a variety of compounds, including pharmaceuticals, fragrances, and pesticides. Bromosaffrole can also act as an enzyme inhibitor, affecting various metabolic pathways in the body.

Safety:

Bromosaffrole is a moderately hazardous compound and should be handled with caution. It can cause skin and eye irritation, and inhalation of high concentrations can cause respiratory irritation, headache, dizziness, and nausea. Bromosaffrole is also a flammable substance and should be stored in a cool, dry, and well-ventilated area away from ignition sources.

Side Effects:

Bromosaffrole has no direct side effects on humans, as it is not intended for human consumption.

Dosing Information:

Bromosaffrole dosing information is not relevant, as it is not intended for human consumption.

Conclusion:

Bromosaffrole is an organic compound commonly used as a chemical intermediate in the synthesis of pharmaceuticals, fragrances, and pesticides. Its potential effects include acting as an enzyme inhibitor, affecting various metabolic pathways in the body. However, due to its moderately hazardous properties, Bromosaffrole should be handled with caution and is not intended for human consumption as a direct treatment.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code